Matthew Love, MD
Urology · Fairfield, OHNPI 1942643820
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $47,654 of the $66,725 with a category attached, or 71.4%. Calyxo, Inc. accounts for 90.3% of it on its own, with 29 other manufacturers making up the rest. 2025 is the largest year on record at $39,486, more than ten times the $428 reported in 2019. Among urology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 321 payments — averaging $207.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Calyxo, Inc.$60K
- Teleflex LLC$1K
- Boston Scientific$783
- Johnson & Johnson$728
- Coloplast$622
- Astellas Pharma US Inc$492
- plus $2K from 24 others
What the payments were for
- Consulting fees$47,65471%
- Travel & lodging$9,94915%
- Food & beverage$8,82313%
- Education$2980%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Calyxo, Inc. | 74 | $60,284 |
| Teleflex LLC | 9 | $1,425 |
| Boston Scientific | 9 | $783 |
| Johnson & Johnson | 37 | $728 |
| Coloplast | 51 | $622 |
| Astellas Pharma US Inc | 30 | $492 |
| Dendreon Pharmaceuticals LLC | 10 | $238 |
| Axonics, Inc. | 4 | $169 |
| Tolmar Pharmaceuticals, Inc. | 9 | $164 |
| Urogen Pharma, Inc. | 9 | $160 |
| Neotract Inc. | 2 | $137 |
| Ferring Pharmaceuticals Inc. | 5 | $134 |
| Dornier Medtech America, Inc | 1 | $128 |
| Pfizer | 9 | $128 |
| Bayer | 7 | $125 |
| Olympus America Inc. | 7 | $120 |
| Medtronic(2 entities) | 6 | $109 |
| Merck | 5 | $107 |
| Sun Pharmaceutical Industries Inc. | 5 | $104 |
| Sumitomo Pharma America, Inc. | 5 | $88 |
| AbbVie | 6 | $86 |
| Immunitybio, Inc. | 2 | $83 |
| Urovant Sciences Inc | 4 | $59 |
| AstraZeneca | 4 | $53 |
| KARL Storz Endoscopy-america | 2 | $50 |
| Accord Healthcare, Inc. | 3 | $47 |
| Myovant Sciences Inc. | 2 | $40 |
| Amgen | 2 | $25 |
| Antares Pharma, Inc. | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CVAC Aspiration System$59,324
- UroLift$1,250
- LITHOCLAST$145
- Erleada$142
- Dornier MedTech$128
- Axonics r-SNM System$127
How this compares
$66,725 in reported general payments places this provider in the 95th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 85 | $71,629 |
| GemtesaVibegron | 48 | $38,641 |
| OrgovyxRelugolix | 13 | $35,558 |
| Potassium Citrate ErPotassium Citrate | 82 | $8,989 |
| Tamsulosin Hcl | 640 | $8,297 |
| Finasteride | 176 | $2,318 |
| Solifenacin Succinate | 48 | $1,338 |
| Oxybutynin Chloride ErOxybutynin Chloride | 29 | $724 |
| NitrofurantoinNitrofurantoin Macrocrystal | 16 | $475 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 50 | $456 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 18 | $441 |
| Cefdinir | 15 | $240 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 77 | $220 |
| Indapamide | 15 | $190 |
| Ciprofloxacin Hcl | 40 | $164 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa, Orgovyx | $88 | $74,19961 claims |
| Astellas Pharma US IncMyrbetriq | $492 | $71,62985 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 485 urology providers in Ohio.
Other urology in Fairfield
- Lawrence GervasiMiddleburg Heights$1.1M
- Howard GoldmanCleveland$721K
- Ronney AbazaWorthington$374K
- Sriharan SivalingamCleveland$276K
- Sandip VasavadaCleveland$263K
- Jihad KaoukCleveland$234K
- Benjamin MartinGahanna$205K
- Ruben OlivaresCleveland$184K
- Abhinav SidanaCincinnati$174K
- Raymond RackleyCleveland$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.